Delsorelin Acetate API
GnRH Agonist Peptide for Long-Term Veterinary Estrus Suppression
Delsorelin Acetate is a high-purity synthetic GnRH agonist widely used in veterinary estrus suppression programs that require long-term hormonal control rather than short-term cycle manipulation. Supplied as a peptide raw material (API), it is primarily intended for veterinary pharmaceutical manufacturers developing long-acting implants and controlled-release formulations.
Delsorelin Acetate for Estrus Suppression in Veterinary Applications
Due to the extended duration of action required in estrus suppression, peptide stability, batch consistency, and regulatory-grade documentation are critical factors influencing formulation success and product approval.
This Delsorelin Acetate peptide is designed for reproductive management programs where predictable and sustained hormonal suppression is essential. It is most commonly evaluated during early-stage formulation and scale-up by companies working on implantable or depot veterinary products.
Technical Identity & Release Specifications
▸ CAS Number: 57773-63-4
▸ Molecular Nature: Synthetic GnRH agonist (acetate salt)
▸ Appearance: White to off-white lyophilized or crystalline powder
▸ Purity: ≥ 98% (HPLC, batch-specific)
▸ Formulation Status: Peptide API (not a finished dosage form)
▸ Documentation Provided: COA, MSDS / TDS
Peptide Identity Confirmation
- Impurity profile verification
- Packaging options for R&D and commercial supply
- Small quantities for formulation evaluation
- Scalable bulk packaging
- Batch release only after identity and purity confirmation
Why Delsorelin Acetate Is Chosen for Estrus Suppression Projects
Long-Term Program Compatibility
Estrus suppression requires consistent peptide performance over extended release periods. High-quality upstream APIs ensure predictable biological behavior.
Manufacturing Consistency
Implant and depot formulations demand minimal batch-to-batch variability to avoid reformulation challenges during scale-up.
Regulatory Readiness
Complete analytical documentation and batch traceability streamline regulatory submissions and registrations across markets.
Handling & Storage Guidelines
- Store sealed and dry immediately upon receipt
- Short-term storage: 2–8 °C
- Long-term storage: −20 °C
- Avoid repeated freeze–thaw cycles
- Allow containers to reach room temperature before opening
- Reconstitution should follow internal peptide SOPs
These precautions are especially important for long-acting veterinary delivery systems.
Packaging & Supply Logistics
- Moisture-resistant primary packaging with desiccant
- Clear batch and lot identification
- Temperature-controlled shipping when required
- Packaging for R&D and commercial production
- Flexible supply aligned with development milestones
Typical Procurement Process
1. Early Evaluation
R&D teams order samples to assess purity, handling, and formulation compatibility.
2. Internal Qualification
Quality teams review analytical data and define acceptance criteria.
3. Project Supply
Following approval, manufacturers transition to planned bulk supply with consistent specifications and delivery timelines.
Frequently Asked Questions (FAQs)
Q: Is Delsorelin Acetate intended for direct veterinary administration?
A: No. It is supplied strictly as a peptide API for formulation and manufacturing.
Q: Who typically purchases this material?
A: Veterinary pharmaceutical companies developing estrus suppression implants.
Q: Are small quantities available?
A: Yes. Sample-scale quantities are available for formulation trials.
Q: Is long-term supply supported?
A: Yes. Bulk supply agreements can be established following qualification.
Hot Tags: delsorelin acetate estrus suppression, China delsorelin acetate estrus suppression manufacturers, suppliers, factory, Deslorelin, Fertirelin Acetate, PMSG, Buserelin Acetate, 79561-22-1, Pregnant Mare Serum Gonadotropin
